liver cirrhosis
Conditions
Interventions
Gold Standard:1. etiology HBV/HCV
2. laborotary test transaminase/Bilirubin/albumin
Index test:1. 
stage
2. 
CT/MR/US.
Sponsors
Beijing Shijitan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: liver cirrhosis, with or without gastrointestinal bleeding
Exclusion criteria
Exclusion criteria: 1. exclusion of CT examination: (1) patient who is allergic to any component of Iodine contrast agents; (2) patient with hyperthyroidism or malignant thyroid tumor; (3) Patient with severe damage of renal function, defined as GFR<30mL/min1.73m2; (4) Pregnant or maybe pregnant woman; (5) Patient without good consciousness who may not complete the examination; (6) Patient with serious heart failure(NYHA 3-4); (7) patient with other X-ray examination within 72 hours to 7days before the contrast enhanced CT examination; (8) patient with other clinical trial within 30 days before the contrast enhanced CT examination; 2. Exclusion of MR examination: (1) patient who is allergic to any component of gadolinium contrast agents; (2) Patient with severe damage of renal function, defined as GFR<30mL/min1.73m2; (3) Patient with pacemaker, heart valve or other implants which cannot approach strong magnetic field; (4) patients with claustrophobia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ID;BF;BV;HAF;MTT;PVP;HVPG;Portal venography image quality; | — |
Countries
China
Contacts
Public ContactWang Ren-gui
Beijing Shijitan Hospital, Capital Medical University
Outcome results
None listed